First ever medicine for crippling genetic kidney disease added to PBS
The Liberal National Government will list a new medicine for adults with genetic kidney disease on the Pharmaceutical Benefits Scheme (PBS), saving patients around $23,000 a year. Jinarc® (tolvaptan) will be available through the PBS from 1 January 2019. It is the first effective drug treatment for autosomal dominant polycystic kidney disease (ADPKD)…